跳至主要内容
临床试验/NL-OMON44694
NL-OMON44694已完成4 期

Immunological effect of early extra MMR immunization in infants between 6 and 12 months of age in an outbreak setting - Immunological effect of early extra MMR immunization (EMI)

RIVM0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Group 1: infants receiving (or having received) MMR-0 between 6-12 months of age and who are about to receive the MMR-1 at 14 months of age;Group 2: infants not receiving MMR-0 and who are about to receive the MMR-1 at 14 months of age

排除标准

  • Encountered measles infection earlier in life;Receiving immunosuppressive medication;Presence of a serious disease that requires medical care that can interfere with the results of the study;Known or expected allergy/hypersensitivity against one of the vaccine ingredients;Known or suspected immunological disorder;Bleeding disorders

研究者

发起方
RIVM

相似试验